Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Probiotics for people with cystic fibrosis

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD012949Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 12 febrero 2018see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Fibrosis quística y enfermedades genéticas

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Michael J Coffey

    School of Women's and Children's Health, University of New South Wales, Sydney, Australia

    Junior Medical Officers Department, Sydney Children's Hospital, Sydney, Australia

  • Millie Garg

    School of Women's and Children's Health, University of New South Wales, Sydney, Australia

  • Nusrat Homaira

    School of Women's and Children's Health, University of New South Wales, Sydney, Australia

  • Adam Jaffe

    School of Women's and Children's Health, University of New South Wales, Sydney, Australia

    Respiratory Department, Sydney Children's Hospital, Sydney, Australia

  • Chee Y Ooi

    Correspondencia a: School of Women's and Children's Health, University of New South Wales, Sydney, Australia

    [email protected]

    Gastroenterology Department, Sydney Children's Hospital, Sydney, Australia

Contributions of authors

Protocol 2017

Dr Michael J. Coffey (MJC) designed the review and drafted the protocol. Millie Garg (MG), Dr Nusrat Homaira (NH) and Professor Adam Jaffe (AJ) all revised the protocol. Dr Chee Y. Ooi (CYO) conceived the study and revised the protocol.

Roles and Responsibilities

Task

Author(s) responsible

Protocol stage: draft the protocol

MJC, NH, AJ and CYO

Review stage: select which trials to include (2 + 1 arbiter)

MJC and MG with CYO as arbiter

Review stage: extract data from trials (2 people)

MJC and MG

Review stage: enter data into RevMan

MJC

Review stage: carry out the analysis

MJC and NH

Review stage: interpret the analysis

MJC, NH, AJ and CYO

Review stage: draft the final review

MJC and CYO

Review stage: draft the final review

MJC, MG, NH, AJ and CYO

Update stage: update the review

MJC and CYO

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • National Institute for Health Research, UK.

    This systematic review was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group.

Declarations of interest

Drs Chee Y. Ooi, Michael J. Coffey and Adam Jaffe are conducting an international, multicentre, double‐blind, randomised, placebo‐controlled study on probiotics for infants and children with cystic fibrosis (Australian and New Zealand Clinical Trials Registry Number: ACTRN12616000797471p).

Millie Garg and Dr Nusrat Homaira have no known conflicts.

Acknowledgements

This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the Cochrane Cystic Fibrosis and Genetic Disorders Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.

We would like to acknowledge the support of Professor Katrina Willaims and Cochrane Australia. We also acknowledge the support of the Sydney Children's Hospital Foundation, the Australian Government Department of Education and Training, and the staff at the School of Women's and Children's Health, Faculty of Medicine, University of New South Wales.

Version history

Published

Title

Stage

Authors

Version

2020 Jan 22

Probiotics for people with cystic fibrosis

Review

Michael J Coffey, Millie Garg, Nusrat Homaira, Adam Jaffe, Chee Y Ooi

https://doi.org/10.1002/14651858.CD012949.pub2

2018 Feb 12

Probiotics for people with cystic fibrosis

Protocol

Michael J Coffey, Millie Garg, Nusrat Homaira, Adam Jaffe, Chee Y Ooi

https://doi.org/10.1002/14651858.CD012949

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.